The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational ...
The Swiss aseptic fill-finish manufacturing specialist Baccinex has become the latest in a string of acquisitions by the ...
The global contract development and manufacturing organization ​ (CDMO), Samsung Biologics, announced this week that it has ...
CEO Dexter Tjoa shares insights on the company’s journey, from early barcoding breakthroughs to embracing advanced ...
High-level results from an ongoing clinical trial make Astrazeneca’s combination treatment the first to show benefit in a subtype of prostate cancer. AstraZeneca has reported positive results from the ...
From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has ...
The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition.
eCOA and ePRO (electronic patient-reported outcome) technology are transforming clinical trials, offering streamlined processes for patients, sites, and sponsors. In this Q&A, Steve shares how ...
Muvalaplin significantly lowered lipoprotein(a) levels, reducing the risk of cardiovascular events in high-risk adults. Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its ...
By focusing on innovative, long-lasting pain relief methods, Brixton is well-positioned to contribute to the shift away from opioid dependence. The company’s technologies align with the objectives of ...